Strategies for Developing Sensitive and Automated LC-MS/MS Assays of a Pharmaceutical Compound and Its Metabolite from Whole Blood Matrix
When compared with biological samples in other matrices (plasma, urine, etc.) that are typically seen in bioanalytical applications, whole blood samples present unique challenges in method development, because of the viscous nature of blood and complexity of its constituents. In this article, we hav...
Main Authors: | Raymond N. Xu, Jill Polzin, Michelle Kranz, Phillip Vaca, Maria Metchkarova, Matthew J. Rieser, Tawakol A. El-Shourbagy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/2/2/159/ |
Similar Items
-
Quantitative Determination of ABT-925 in Human Plasma by On-Line SPE and LC-MS/MS: Validation and Sample Analysis in Phase II Studies
by: Katty Wan, et al.
Published: (2010-05-01) -
LC–MS/MS assay for olanzapine in human plasma and its application to a bioequivalence study
by: Dinesh S. Patel, et al.
Published: (2012-10-01) -
Effect of Mobile Phase pH on the Electrospray Ionization Efficiency and Qualitative Analysis of Pharmaceuticals in ESI + LC-MS/MS
by: Bakar, N.K.A, et al.
Published: (2019) -
DEVELOPMENT AND VALIDATION OF A LC-ESI-MS/MS METHOD FOR SIMULTANEOUS WHOLE BLOOD ANALYSIS OF 51 NEW PSYCHOACTIVE SUBSTANCES
by: Maria Cristina Franck, et al.
Published: (2019-12-01) -
Global metabolite profiling based on GC–MS and LC–MS/MS analyses in ABF3-overexpressing soybean with enhanced drought tolerance
by: Kyong-Hee Nam, et al.
Published: (2019-03-01)